Stockscreener 앱 받기
74.69
2.25%
1.4649
전일 마감가:
$73.22
열려 있는:
$73.21
하루 거래량:
1,116
Relative Volume:
0.13
시가총액:
$281.93M
수익:
-
순이익/손실:
-
주가수익비율:
-
EPS:
-
순현금흐름:
-
1주 성능:
+1.96%
1개월 성능:
+7.15%
6개월 성능:
+20.21%
1년 성능:
+9.78%
1일 변동 폭
$73.21
$74.60
1주일 범위
$72.27
$74.60
52주 변동 폭
$54.52
$74.60
Invesco Biotechnology Genome Etf Stock (PBE) Company Profile
PBE을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
PBE
Invesco Biotechnology Genome Etf
|
74.58 | 281.93M | 0 | 0 | 0 | 0.00 |
|
VTI
Vanguard Total Stock Market Etf
|
335.30 | 417.53B | 0 | 0 | 0 | 0.00 |
|
SPY
Spdr S P 500 Etf Trust
|
682.19 | 372.57B | 0 | 0 | 0 | 0.00 |
|
IVV
Ishares Core S P 500 Etf
|
685.60 | 253.41B | 0 | 0 | 0 | 0.00 |
|
VB
Vanguard Small Cap Etf
|
254.06 | 160.59B | 0 | 0 | 0 | 0.00 |
|
QQQ
Invesco Qqq Trust Series 1
|
630.59 | 124.43B | 0 | 0 | 0 | 0.00 |
Invesco Biotechnology Genome Etf 주식(PBE)의 최신 뉴스
Genome ETF stock compared to rivalsJuly 2025 News Drivers & Precise Swing Trade Alerts - Trung tâm Dự báo KTTV quốc gia
Genome ETF stockChart Signals & Fast Exit and Entry Trade Guides - newser.com
Wealth Enhancement Advisory Services LLC Sells 2,491 Shares of Invesco Biotechnology & Genome ETF $PBE - Defense World
Is Invesco Biotechnology & Genome ETF (PBE) a Strong ETF Right Now? - sharewise.com
Genome ETF stock benefit from mergersTrade Risk Summary & Consistent Return Strategy Ideas - newser.com
The Best Biotech ETFs to Buy - Kiplinger
Should You Invest in the Invesco Biotechnology & Genome ETF (PBE)? - MSN
Genome ETF stock deliver strong annual returnsJuly 2025 Drop Watch & Weekly Watchlist for Consistent Profits - newser.com
Pharma ETFs In A Tariff Storm: How Investors Can Hedge Risk - Benzinga
Signet Financial Management LLC Grows Position in Invesco Biotechnology & Genome ETF $PBE - Defense World
Invesco Biotechnology & Genome ETF $PBE Position Decreased by HighTower Advisors LLC - Defense World
7 Best Biotech ETFs to Buy Now - US News Money
Invesco Biotechnology & Genome ETF (NYSEARCA:PBE) Shares Sold by LPL Financial LLC - Defense World
Cetera Investment Advisers Has $1.34 Million Holdings in Invesco Biotechnology & Genome ETF (NYSEARCA:PBE) - Defense World
Global X Genomics & Biotechnology ETF (NASDAQ:GNOM) Shares Acquired by Private Advisor Group LLC - Defense World
Invesco (IVZ) Rallies 0.18% to Highest Since July 2025 Amid Asset Management Sector Reassessment - AInvest
PBE ETF: A Comprehensive Guide to Its Fundamentals and Performance - AInvest
Should You Invest in the Invesco S&P 500 Equal Weight Financials ETF (RSPF)? - Yahoo Finance
Invesco Nasdaq Biotechnology ETF IBBQ 2025Q2 Earnings Preview Upside Potential on Biotech Sector Growth - AInvest
Invesco Biotechnology & Genome ETF (NYSEARCA:PBE) Shares Purchased by Wealth Enhancement Advisory Services LLC - Defense World
Janney Montgomery Scott LLC Has $344,000 Holdings in Invesco Biotechnology & Genome ETF (NYSEARCA:PBE) - Defense World
Invesco Exchange-Traded Fund TrustInvesco Biotechnology & Genome ETF Reports Earnings Results for the Full Year Ended April 30, 2025 - MarketScreener
5 Best ETFs Tracking CRISPR Gene Editing - The Motley Fool
Invesco Biotechnology & Genome ETF (NYSEARCA:PBE) Short Interest Update - Defense World
Farther Finance Advisors LLC Acquires 6,201 Shares of Invesco Biotechnology & Genome ETF (NYSEARCA:PBE) - Defense World
Wealth Enhancement Advisory Services LLC Raises Stake in Invesco Biotechnology & Genome ETF (NYSEARCA:PBE) - Defense World
Two Sigma Investments LP Cuts Position in Invesco Biotechnology & Genome ETF (NYSEARCA:PBE) - Defense World
PDS Biotechnology (NASDAQ:PDSB) Receives Buy Rating from HC Wainwright - Defense World
Citadel Advisors LLC Grows Stake in Innovator U.S. Equity Ultra Buffer ETF – January (BATS:UJAN) - Defense World
8,551 Shares in Invesco Biotechnology & Genome ETF (NYSEARCA:PBE) Acquired by Citadel Advisors LLC - Defense World
Bank of America Corp DE Has $4.59 Million Position in Invesco Biotechnology & Genome ETF (NYSEARCA:PBE) - Defense World
Invesco Biotechnology & Genome ETF (NYSEARCA:PBE) Stake Lessened by Cetera Investment Advisers - Defense World
Stifel Financial Corp Acquires 16,892 Shares of RiverNorth Managed Duration Municipal Income Fund II, Inc. (NYSEARCA:RMMZ) - Defense World
Vericel Co. (NASDAQ:VCEL) Shares Sold by Tower Research Capital LLC TRC - Defense World
Stifel Financial Corp Sells 600 Shares of SRH Total Return Fund, Inc. (NYSE:STEW) - Defense World
Stifel Financial Corp Sells 1,457 Shares of Invesco Biotechnology & Genome ETF (NYSEARCA:PBE) - Defense World
Stifel Financial Corp Grows Stock Holdings in Schwab U.S. REIT ETF (NYSEARCA:SCHH) - Defense World
Susquehanna International Group LLP Makes New Investment in VictoryShares Core Intermediate Bond ETF (NASDAQ:UITB) - Defense World
Stifel Financial Corp Acquires 5,291 Shares of T. Rowe Price Dividend Growth ETF (NYSEARCA:TDVG) - Defense World
Hsbc Holdings PLC Grows Position in Terns Pharmaceuticals, Inc. (NASDAQ:TERN) - Defense World
Hsbc Holdings PLC Purchases 16,554 Shares of MaxCyte, Inc. (NASDAQ:MXCT) - Defense World
Barclays PLC Buys 10,174 Shares of FT Vest U.S. Equity Enhance & Moderate Buffer ETF – January (NYSEARCA:XJAN) - Defense World
16,974 Shares in VNET Group, Inc. (NASDAQ:VNET) Bought by Tower Research Capital LLC TRC - Defense World
Invesco Biotechnology Genome Etf (PBE) 재무 분석
Invesco Biotechnology Genome Etf (PBE)에 대한 금융 데이터가 없습니다. 더 많은 정보를 위해 다른 주식을 확인해보세요.
매출
순이익
현금흐름
주당 순 이익
0.13%
0.70%
자본화:
|
볼륨(24시간):